NCT05323812View on ClinicalTrials.gov

ASURE: Alzheimer Study Using oRal Edaravone

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Alzheimer Disease
Interventions
DRUG

TW001

daily dose of 100 mg TW001/placebo

DRUG

Placebo

daily dose of 100 mg TW001/placebo

Trial Locations (6)

10000

University Hospital Centre Zagreb, Zagreb

31000

University Hospital Centre Osijek, Osijek

5223 LA

Brain Research Center Den Bosch, 's-Hertogenbosch

1081 GN

Brain Research Center Amsterdam, Amsterdam

5022 GC

ETZ Elisabeth ziekenhuis, Tilburg

8025 AZ

Brain Research Center Zwolle, Zwolle

All Listed Sponsors
lead

Treeway B.V.

INDUSTRY